RESUMO
The pleiotropic biological activities of interleukin-1 (IL-1) are mediated by its type I receptor (IL-1RI). When the ligand binds, IL-1RI initiates a signaling cascade that results in the activation of the transcription regulator nuclear factor kappa B (NF-kappa B). A protein kinase designated IRAK (IL-1 receptor-associated kinase) was purified, and its complementary DNA was molecularly cloned. When human embryonic kidney cells (cell line 293) over-expressing IL-1RI or HeLa cells were exposed to IL-1, IRAK rapidly associated with the IL-1RI complex and was phosphorylated. The primary amino acid sequence of IRAK shares similarity with that of Pelle, a protein kinase that is essential for the activation of a NF-kappa B homolog in Drosophila.
Assuntos
Proteínas de Drosophila , Interleucina-1/metabolismo , Proteínas Quinases/metabolismo , Receptores de Interleucina-1/metabolismo , Sequência de Aminoácidos , Animais , Linhagem Celular , Clonagem Molecular , DNA Complementar/genética , Drosophila , Células HeLa , Humanos , Interleucina-1/farmacologia , Quinases Associadas a Receptores de Interleucina-1 , Dados de Sequência Molecular , Fosforilação , Proteínas Quinases/química , Proteínas Quinases/genética , Proteínas Quinases/isolamento & purificação , Proteínas Serina-Treonina Quinases/química , TransfecçãoRESUMO
Interleukin-4 (IL-4) is an immunomodulatory cytokine secreted by activated T lymphocytes, basophils, and mast cells. It plays an important role in modulating the balance of T helper (Th) cell subsets, favoring expansion of the Th2 lineage relative to Th1. Imbalance of these T lymphocyte subsets has been implicated in immunological diseases including allergy, inflammation, and autoimmune disease. IL-4 may mediate its biological effects, at least in part, by activating a tyrosine-phosphorylated DNA binding protein. This protein has now been purified and its encoding gene cloned. Examination of the primary amino acid sequence of this protein indicates that it is a member of the signal transducers and activators of transcription (Stat) family of DNA binding proteins, hereby designated IL-4 Stat. Study of the inhibitory activities of phosphotyrosine-containing peptides derived from the intracellular domain of the IL-4 receptor provided evidence for direct coupling of receptor and transcription factor during the IL-4 Stat activation cycle. Such observations indicate that IL-4 Stat has the same functional domain for both receptor coupling and dimerization.
Assuntos
Proteínas de Ligação a DNA/metabolismo , Interleucina-4/farmacologia , Receptores Mitogênicos/metabolismo , Transativadores/metabolismo , Fatores de Transcrição/metabolismo , Sequência de Aminoácidos , Sequência de Bases , Linhagem Celular , Clonagem Molecular , Reagentes de Ligações Cruzadas , DNA/metabolismo , Proteínas de Ligação a DNA/química , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/isolamento & purificação , Humanos , Subunidade alfa de Receptor de Interleucina-4 , Modelos Biológicos , Dados de Sequência Molecular , Monócitos/metabolismo , Fosfopeptídeos/metabolismo , Fosfopeptídeos/farmacologia , Fosforilação , Polímeros , Receptores de Superfície Celular , Receptores de Interleucina-4 , Fator de Transcrição STAT6 , Transativadores/química , Transativadores/genética , Transativadores/isolamento & purificação , Fatores de Transcrição/química , Fatores de Transcrição/genéticaRESUMO
The proto-oncogene designated erbB2 or HER2 encodes a 185-kilodalton transmembrane tyrosine kinase (p185erbB2), whose overexpression has been correlated with a poor prognosis in several human malignancies. A 45-kilodalton protein heregulin-alpha (HRG-alpha) that specifically induced phosphorylation of p185erbB2 was purified from the conditioned medium of a human breast tumor cell line. Several complementary DNA clones encoding related HRGs were identified, all of which are similar to proteins in the epidermal growth factor family. Scatchard analysis of the binding of recombinant HRG to a breast tumor cell line expressing p185erbB2 showed a single high affinity binding site [dissociation constant (Kd) = 105 +/- 15 picomolar]. Heregulin transcripts were identified in several normal tissues and cancer cell lines. The HRGs may represent the natural ligands for p185erbB2.
Assuntos
Proteínas de Ligação a DNA/metabolismo , Glicoproteínas/metabolismo , Proteínas Tirosina Quinases/genética , Proteínas Proto-Oncogênicas/genética , Proto-Oncogenes , Sequência de Aminoácidos , Animais , Sequência de Bases , Neoplasias da Mama/genética , Linhagem Celular , Cromatografia Líquida de Alta Pressão , Códon , Meios de Cultura , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/isolamento & purificação , Fator de Crescimento Epidérmico/genética , Feminino , Humanos , Cinética , Dados de Sequência Molecular , Neurregulinas , Sondas de Oligonucleotídeos , Fosforilação , Conformação Proteica , Proto-Oncogene Mas , Receptor ErbB-2 , Homologia de Sequência do Ácido Nucleico , TransfecçãoRESUMO
REK7 is an Eph-related tyrosine kinase receptor expressed exclusively in the nervous system, predominantly in hippocampus and cortex. A soluble REK7-IgG fusion protein, produced to analyze the biological role of REK7, prevents axon bundling in cocultures of cortical neurons with astrocytes, a model of late stage nervous system development and differentiation. Using REK7-IgG as an affinity reagent, we purified and cloned a novel REK7 ligand called AL-1, a GPI-linked protein homologous to other members of an emerging ligand family. Membrane attachment of AL-1 appears necessary for receptor activation, since REK7 on cortical neurons is efficiently activated by transfected cells expressing GPI-linked AL-1, but not by soluble AL-1. Consistent with this, soluble AL-1 blocks axon bundling. Our findings, together with the observation that both molecules are expressed in the brain, suggest a role in the formation of neuronal pathways, a crucial feature of nervous system development and regeneration.
Assuntos
Axônios/ultraestrutura , Encéfalo/metabolismo , Clonagem Molecular , Receptores Proteína Tirosina Quinases/metabolismo , Fatores de Transcrição/genética , Sequência de Aminoácidos , Animais , Axônios/efeitos dos fármacos , Axônios/fisiologia , Sequência de Bases , Northern Blotting , Encéfalo/ultraestrutura , Membrana Celular/metabolismo , Células Cultivadas , Córtex Cerebral/embriologia , Córtex Cerebral/metabolismo , Córtex Cerebral/ultraestrutura , Efrina-A2 , Citometria de Fluxo , Imunofluorescência , Hipocampo/metabolismo , Hipocampo/ultraestrutura , Imunoglobulina G , Ligantes , Dados de Sequência Molecular , Ratos , Ratos Wistar , Proteínas Recombinantes de Fusão , Fatores de Transcrição/química , Fatores de Transcrição/metabolismoRESUMO
N-terminal as well as internal amino acid sequence data were obtained from the GH dependent, insulin-like growth factor (IGF) binding protein, BP-53, purified from human plasma. Based on these sequence data, full-length cDNA clones of BP-53 have been isolated, and the complete deduced sequence of BP-53 determined. This sequence contains a 27 amino acid putative signal sequence followed by a mature protein of 264 amino acids containing 18 cysteine residues clustered near the N- and C-terminus. The deduced protein sequence of BP-53 has 33% amino acid identity including conservation of all 18 cysteine residues with the recently cloned BP-28, a smaller human IGF-binding protein identified in amniotic fluid and also secreted by the cell line HEP G2. Expression of the cloned BP-53 cDNA in mammalian tissue culture cells results in secretion of the protein into the culture medium. This expressed protein is identical to plasma-derived BP-53 in its immunoreactivity, high affinity binding of IGF-I and IGF-II, and mobility on sodium dodecyl sulfate gel electrophoresis.
Assuntos
Proteínas de Transporte/genética , Clonagem Molecular , Regulação da Expressão Gênica , Hormônio do Crescimento/fisiologia , Receptores de Superfície Celular/genética , Sequência de Aminoácidos , Sequência de Bases , Proteínas de Transporte/metabolismo , Hormônio do Crescimento/farmacologia , Humanos , Proteínas de Ligação a Fator de Crescimento Semelhante a Insulina , Dados de Sequência Molecular , Receptores de Superfície Celular/metabolismo , Receptores de SomatomedinaRESUMO
We have determined the major sites responsible for isoaspartate formation during in vitro aging of bovine brain calmodulin under mild conditions. Protein L-isoaspartyl methyltransferase (EC 2.1.1.77) was used to quantify isoaspartate by the transfer of methyl-3H from S-adenosyl-L-[methyl-3H]methionine to the isoaspartyl (alpha-carboxyl) side chain. More than 1.2 mol of methyl-acceptor sites per mol of calmodulin accumulated during a 2-week incubation without calcium at pH 7.4, 37 degrees C. Analysis of proteolytic peptides of aged calmodulin revealed that > 95% of the methylation capacity is restricted to residues in the four calcium-binding domains, which are predicted to be highly flexible in the absence of calcium. We estimate that domains III, IV, and II accumulated 0.72, 0.60, and 0.13 mol of isoaspartate per mol of calmodulin, respectively. The Asn-97-Gly-98 sequence (domain III) is the greatest contributor to isoaspartate formation. Other major sites of isoaspartate formation are Asp-131-Gly-132 and Asp-133-Gly-134 in domain IV, and Asn-60-Gly-61 in domain II. Significant isoaspartate formation was also localized to Asp-20, Asp-22, and/or Asp-24 in domain I, to Asp-56 and/or Asp-58 in domain II, and to Asp-93 and/or Asp-95 in domain III. All of these residues are calcium ligands in the highly conserved EF-hand calcium-binding motif. Thus, other EF-hand proteins may also be subject to isoaspartate formation at these ligands. The results support the idea that isoaspartate formation in structured proteins is strongly influenced by both the C-flanking residue and by local flexibility.
Assuntos
Ácido Aspártico/metabolismo , Cálcio/metabolismo , Calmodulina/química , Sequência de Aminoácidos , Animais , Asparagina/química , Ácido Aspártico/química , Sítios de Ligação , Química Encefálica , Calmodulina/metabolismo , Bovinos , Cromatografia Líquida de Alta Pressão , Concentração de Íons de Hidrogênio , Lisina/química , Metilação , Dados de Sequência Molecular , Fragmentos de Peptídeos/química , Fragmentos de Peptídeos/metabolismo , Conformação Proteica , Proteína D-Aspartato-L-Isoaspartato Metiltransferase , Proteínas Metiltransferases/metabolismo , Fatores de Tempo , Tripsina/metabolismoRESUMO
The isolation and hormonal regulation of two low molecular weight insulin-like growth factor binding proteins (IGFBPs) present in the conditioned medium (CM) of the rat neuroblastoma cell line B104 cells has been performed. IGFBPs were purified by ZnSO4 precipitation, insulin-like growth factor-I 1IGF-I) affinity chromatography, and reverse phase HPLC. Final isolation and N-terminal analysis was accomplished by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, electroblotting to polyvinylidene difluoride membranes, and sequencing of the bound proteins. Two IGFBPs, with apparent Mr of 28K and 24K were coisolated and sequenced. Both proteins had identical N-terminal sequences and appear to be two forms of IGFBP-4. Treatment of the IGFBPs with endoglycosidase-F caused a shift in the apparent Mr of the 28K IGFBP to 24K. However, there was no change in the apparent Mr of the 24K IGFBP. The data from this study suggest that the IGFBP-4 exists as both a glycosylated and nonglycosylated protein. Treatment of B104 cells with IGF-I increased the expression of both the 24K and 28K IGFBPs and also resulted in the appearance of IGFBP-3 and an unknown IGFBP at 29K. When added to subconfluent cells, IGF-I was also mitogenic in B104 cells. Similar to IGF-I, IGF-II treatment increased cell number and resulted in the appearance of IGFBP-3 and the 29K IGFBP. However, IGF-II treatment resulted in a significant decrease (approximately 50%) in the 24K IGFBP and also decreased the 28K IGFBP. This decrease in the expression of the 24K and 28K IGFBPs was dose-dependent and was blocked by addition of IGF-I to the cells. When an IGF-II receptor antibody was added to the cells it mimicked the effects of IGF-II on B104 cells, suggesting that the inhibitory effects of IGF-II are mediated through the type II IGF receptor. Although both IGF-I and IGF-II affected the amount of the 24K IGFBP in the CM, neither peptide affected the expression of the messenger RNA for the 24K IGFBP. In conclusion, we have isolated two IGFBPs from the CM of B104 cells. Both the 24K and 28K IGFBPs appear to be isoforms of the same protein, and sequence data suggest these proteins are two forms of IGFBP-4. IGF-I increases the expression of both of these IGFBPs, whereas IGF-II decreases their expression.(ABSTRACT TRUNCATED AT 400 WORDS)
Assuntos
Proteínas de Transporte/metabolismo , Fator de Crescimento Insulin-Like II/farmacologia , Fator de Crescimento Insulin-Like I/farmacologia , Neuroblastoma/metabolismo , Sequência de Aminoácidos , Animais , Western Blotting , Proteínas de Transporte/isolamento & purificação , Meios de Cultura , Proteínas de Ligação a Fator de Crescimento Semelhante a Insulina , Ligantes , Dados de Sequência Molecular , Neuroblastoma/patologia , Somatomedinas/metabolismo , Células Tumorais CultivadasRESUMO
We have cloned and sequenced novel cDNAs that encode human and murine DNase II, the acidic deoxyribonuclease. Sequence analysis predicts that huDNase II contains an N-terminal signal sequence and that mature DNase II has 344 residues with a calculated molecular mass of 38 032 Da. DNase II is a novel enzyme with no homologies to proteins of known function. Surprisingly, C. elegans appears to possess a family of DNase II homologs. Unlike DNase I-like enzymes that have tissue-specific expression patterns, huDNase II is ubiquituously expressed at low levels. When huDNase II is expressed in human 293 cells, we observe secretion of a novel 42-44 kDa glycoprotein; approximately 20-30% of recombinant human DNase II activity is secreted in this system. The secreted enzyme possesses DNA hydrolytic activity and shares biochemical properties with purified DNase II obtained from other species. We also show that the mechanism by which DNase II cuts DNA is similar to DNase I in that the enzyme produces nicks rather than double-strand cuts.
Assuntos
Endodesoxirribonucleases/genética , Endodesoxirribonucleases/metabolismo , Sequência de Aminoácidos , Animais , Sequência de Bases , Linhagem Celular , Clonagem Molecular , Endodesoxirribonucleases/química , Humanos , Rim , Cinética , Camundongos , Dados de Sequência Molecular , Sondas de Oligonucleotídeos , Fragmentos de Peptídeos/química , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Mapeamento por Restrição , Alinhamento de Sequência , Homologia de Sequência de Aminoácidos , Suínos , TransfecçãoRESUMO
A manual Edman technique is described which allows sequential quantitative determination of from 3 to 10 amino terminal residues on quantities of peptides or proteins down to one nanomole. This is achieved by a fast, efficient method of obtaining the anilinothiazolinone or phenylthiohydantoin amino acid, and quantitating by either back hydrolysis and amino acid analysis or by a new, rapid, high resolution, quasi-isocratic, high-pressure liquid chromatographic procedure. The overall method has been extensively tested successfully on both peptides and proteins of known and unknown amino-terminal sequence and the results included here. In addition, a wide variety of applications relevant to primary structure analysis such as sequencing blocked polypeptides, use of denaturing agents as coupling buffers, reduction of protein or peptide losses on consecutive sequencing and peptide mixture analysis are all incorporated in the methodology outlined.
Assuntos
Sequência de Aminoácidos , Microquímica , Oligopeptídeos/análise , Feniltioidantoína/análogos & derivados , Proteínas/análiseRESUMO
We have identified a carboxylesterase in A. suum that appears to be the homolog of the gut-specific C. elegans ges-1 enzyme. The A. suum esterase was purified and its N-terminal sequence found to be 50% identical to the C. elegans ges-1 protein. We have used isoelectric focusing analysis to demonstrate that, unlike the C. elegans ges-1 esterase, the A. suum enzyme is not restricted to the gut but is expressed in a wide range of tissues.
Assuntos
Ascaris suum/enzimologia , Proteínas de Caenorhabditis elegans , Caenorhabditis elegans/enzimologia , Hidrolases de Éster Carboxílico/química , Intestinos/enzimologia , Sequência de Aminoácidos , Animais , Carboxilesterase , Feminino , Dados de Sequência Molecular , Especificidade de Órgãos , Homologia de Sequência de AminoácidosAssuntos
Fatores de Crescimento Endotelial/isolamento & purificação , Linfocinas/isolamento & purificação , Adeno-Hipófise/metabolismo , Sequência de Aminoácidos , Animais , Bioensaio/métodos , Bovinos , Divisão Celular/efeitos dos fármacos , Linhagem Celular , Células Cultivadas , Cromatografia de Afinidade/métodos , Cromatografia Líquida de Alta Pressão/métodos , Clonagem Molecular/métodos , DNA/genética , DNA/isolamento & purificação , Fatores de Crescimento Endotelial/genética , Fatores de Crescimento Endotelial/metabolismo , Fatores de Crescimento Endotelial/farmacologia , Endotélio Vascular/citologia , Endotélio Vascular/efeitos dos fármacos , Biblioteca Gênica , Humanos , Linfocinas/genética , Linfocinas/metabolismo , Linfocinas/farmacologia , Dados de Sequência Molecular , Adeno-Hipófise/citologia , RNA Mensageiro/genética , RNA Mensageiro/isolamento & purificação , Proteínas Recombinantes/isolamento & purificação , Proteínas Recombinantes/farmacologia , Transfecção , Fator A de Crescimento do Endotélio Vascular , Fatores de Crescimento do Endotélio VascularAssuntos
Mapeamento de Peptídeos/métodos , Benzoatos , Biotecnologia , Eletroforese/métodos , Fluorescência , Corantes Fluorescentes , Lactoglobulinas/isolamento & purificação , Lasers , Mapeamento de Peptídeos/instrumentação , Mapeamento de Peptídeos/estatística & dados numéricos , Quinolinas , Reprodutibilidade dos TestesRESUMO
Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) is one of the most useful techniques for determining the mass of biomolecules, with exceptional capabilities for mass analysis of peptides. Relative to other ionization techniques, it provides high sensitivity and excellent tolerance of salt and other common buffer components. Routine detection limits for peptides are in the subpicomole range. The ions commonly observed are the protonated molecules (M+H(+)), which makes data analysis relatively easy. This overview discusses instrument configuration and calibration, sample preparation, along with specific approaches for analyzing peptide mixtures, synthetic peptides, and chemical modifications of peptides.
Assuntos
Peptídeos/análise , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz/métodos , Estrutura Molecular , Peptídeos/química , Reprodutibilidade dos Testes , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz/instrumentaçãoRESUMO
In reversed-phase HPLC, peptides are separated on a hydrophobic stationary phase and eluted with a gradient of increasing organic solvent concentration. Protocols describing the separation of peptides in 5- to 500-pmol quantities via narrow-bore (2-mm-i.d.) or microbore (1-mm-i.d.) columns, as well as for the separation of peptides in quantities <5 pmol are provided in this unit. Capillary HPLC columns require a gradient flow rate of 3 to 5 omponents present in a small sample prior to automated sequencing is possible via the procedures for matrix-assisted laser desorption/ionization (MALDI) mass spectrometry and capillary electrophoresis.
Assuntos
Cromatografia Líquida de Alta Pressão/métodos , Peptídeos/isolamento & purificação , Animais , Eletroforese Capilar , Humanos , Interações Hidrofóbicas e Hidrofílicas , Mapeamento de Peptídeos , Solventes , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por MatrizRESUMO
A growth factor for vascular endothelial cells was identified in the media conditioned by bovine pituitary follicular cells and purified to homogeneity by a combination of ammonium sulfate precipitation, heparin-sepharose affinity chromatography and two reversed phase HPLC steps. The growth factor was a cationic, heat stable and relatively acid stable protein and had a molecular weight, as assessed by silver-stained SDS-PAGE gel, of approximately 45,000 under non reducing conditions and approximately 23,000 under reducing conditions. The purified growth factor had a maximal mitogenic effect on adrenal cortex-derived capillary endothelial cells at the concentration of 1-1.2 ng/ml (22-26 pM). Further characterization of the bioactivity of the growth factor reveals that it exerts mitogenic effects also on vascular endothelial cells isolated from several districts but not on adrenal cortex cells, lens epithelial cells, corneal endothelial cells, keratynocytes or BHK-21 fibroblasts, indicating that its target cells specificity is unlike that of any previously characterized growth factor. Microsequencing reveals a unique N-terminal amino acid sequence. On the basis of its apparent target cell selectivity, we propose to name this factor vascular endothelial growth factor (VEGF).
Assuntos
Endotélio Vascular/citologia , Substâncias de Crescimento/isolamento & purificação , Hipófise/análise , Animais , Bovinos , Divisão Celular/efeitos dos fármacos , Cromatografia Líquida de Alta Pressão , Técnicas de Cultura , Relação Dose-Resposta a Droga , Substâncias de Crescimento/farmacologia , Heparina/metabolismo , Peso MolecularRESUMO
The transcription factor NF-kappaB coordinates the activation of numerous genes in response to pathogens and pro-inflammatory cytokines, and is, therefore, vital in the development of acute and chronic inflammatory diseases. NF-kappaB is activated by phsophorylation of its inhibitory subunit, IkappaB-alpha, on serine residues 32 and 36 by cytokine-activated IKB kinases (IKKs); this phosphorylation precedes rapid degradation of IkappaB. IKK-alpha and IKK-beta isozymes are found in large complexes of relative molecular mass 700,000-900,000 (M(r) 70K-90K), but little is known about other components that organize and regulate these complexes. IKK-alpha was independently discovered as a NF-kappaB-inducing kinase (NIK)-associated protein in a yeast two-hybrid screen, and IKK-beta was also identified by homology screening. It is, however, unknown whether NIK is part of the IKK complex. Here we isolate large, interleukin-1-inducible IKK complexes that contain NIK, IKK-alpha, IKK-beta, IkappaB-alpha, NF-kappaB/RelA and a protein of M(r) 150K. This latter component is a new protein, termed IKK-complex-associated protein (IKAP), which can bind NIK and IKKs and assemble them into an active kinase complex. We show that IKAP is a scaffold protein and a regulator for three different kinases involved in pro-inflammatory cytokine signalling.
Assuntos
Proteínas de Transporte/metabolismo , Proteínas Serina-Treonina Quinases/química , Sequência de Aminoácidos , Proteínas de Transporte/genética , Proteínas de Transporte/isolamento & purificação , Linhagem Celular Transformada , Clonagem Molecular , Indução Enzimática , Quinase I-kappa B , Interleucina-1/metabolismo , Dados de Sequência Molecular , Matriz Nuclear/enzimologia , Fosforilação , Homologia de Sequência de Aminoácidos , Transdução de Sinais , Fatores de Elongação da Transcrição , Fator de Necrose Tumoral alfa/metabolismoRESUMO
Hypoxia, reoxygenation, and the tyrosine phosphatase inhibitor pervanadate activate the transcription factor NF-kappaB, involving phosphorylation of its inhibitor IkappaB-alpha on tyrosine 42. This modification does not lead to degradation of IkappaB by the proteasome/ubiquitin pathway, as is seen on stimulation of cells with proinflammatory cytokines. It is currently unknown how tyrosine-phosphorylated IkappaB is removed from NF-kappaB. Here we show that p85alpha, the regulatory subunit of PI3-kinase, specifically associates through its Src homology 2 domains with tyrosine-phosphorylated IkappaB-alpha in vitro and in vivo after stimulation of T cells with pervanadate. This association could provide a mechanism by which newly tyrosine-phosphorylated IkappaB is sequestered from NF-kappaB. Another mechanism by which PI3-kinase contributed to NF-kappaB activation in response to pervanadate appeared to involve its catalytic p110 subunit. This was evident from the inhibition of pervanadate-induced NF-kappaB activation and reporter gene induction by treatment of cells with nanomolar amounts of the PI3-kinase inhibitor wortmannin. The compound had virtually no effect on tumor necrosis factor- and interleukin-1-induced NF-kappaB activities. Wortmannin did not inhibit tyrosine phosphorylation of IkappaB-alpha or alter the stability of the PI3-kinase complex but inhibited Akt kinase activation in response to pervanadate. Our data suggest that both the regulatory and the catalytic subunit of PI3-kinase play a role in NF-kappaB activation by the tyrosine phosphorylation-dependent pathway.
Assuntos
Proteínas de Ligação a DNA/metabolismo , NF-kappa B/metabolismo , Fosfatidilinositol 3-Quinases/metabolismo , Androstadienos/farmacologia , Inibidores Enzimáticos/farmacologia , Humanos , Proteínas I-kappa B , Células Jurkat , Peptídeos/metabolismo , Fosforilação , Fosfotirosina/metabolismo , Ativação Transcricional/genética , Fator de Necrose Tumoral alfa/farmacologia , Vanadatos/farmacologia , Wortmanina , Domínios de Homologia de src/genéticaRESUMO
The borate-insoluble chitin-protein complex, CB-I, from prepupal sarcophagid larvae was cleaved with chymotrypsin and trifluoromethanesulfonic acid releasing a polypeptide fragment of Mr 68 000. The intact glycoprotein was blocked at the C terminus; the N-terminal sequence of Asp-Val-Ala-His-Tyr was not homologous with seven of the borate-soluble nonglycosylated structural proteins. Bityrosine was identified as a component of the primary chain, both half-residues occupied in peptide linkages. Sclerotization initiated a decline in bityrosine coincident with the addition of soluble proteins to the tanned matrix. The chitin-protein complex also included bound peroxidase, propolyphenol oxidase, and an o-diphenol subject to oxidation on activation of the zymogen. In the course of the oxidation N termini declined in accordance with the formation of 1,4 quinonoid cross-links.
Assuntos
Quitina/metabolismo , Dípteros/metabolismo , Proteínas/metabolismo , Sequência de Aminoácidos , Quimotripsina/metabolismo , Dípteros/crescimento & desenvolvimento , Glicoproteínas/análise , Larva/metabolismo , Mesilatos/metabolismo , Peso Molecular , SolubilidadeRESUMO
Medium conditioned by bovine pituitary follicular cells paradoxically inhibits the growth of adult bovine aortic endothelial (ABAE) cells at dilutions that are instead mitogenic to adrenal cortex capillary endothelial (ACCE) cells, suggesting that follicular cells secrete a growth inhibitor with a selectivity for ABAE cells. The ABAE cell inhibitory activity was purified to apparent homogeneity by a combination of size-exclusion chromatography, ion-exchange chromatography, and two reversed-phase steps on a C4 column. Microsequencing of the purified material revealed a single NH2-terminal amino acid sequence, identical to that of leukemia inhibitory factor (LIF), a glycoprotein originally identified by its ability to inhibit the growth of MT1 mouse leukemia cells and subsequently found to have numerous effects. Recombinant human LIF inhibited the growth of ABAE cells as effectively as transforming growth factor beta (TGF beta 1). However, it failed to inhibit markedly the growth of ACCE cells, whereas TGF beta 1 dramatically inhibited their growth. Recombinant human LIF also failed to induce a significant angiogenic response in the chicken chorioallantoic membrane, indicating that, unlike TGF beta, LIF probably does not induce the release of direct-acting angiogenic factors from inflammatory cells. The presence of LIF in follicular cells may relate to the peculiar vascular organization of the pituitary gland, where no arteries reach the pars distalis and all of the blood supply to this area is by capillaries.
Assuntos
Endotélio Vascular/citologia , Inibidores do Crescimento/metabolismo , Interleucina-6 , Linfocinas/metabolismo , Hipófise/fisiologia , Sequência de Aminoácidos , Animais , Bovinos , Células Cultivadas , Embrião de Galinha , Inibidores do Crescimento/química , Técnicas In Vitro , Fator Inibidor de Leucemia , Linfocinas/química , Dados de Sequência Molecular , Neovascularização Patológica , Hipófise/citologiaRESUMO
An HPLC system incorporating a packed capillary C18 column has been utilized for high sensitivity peptide mapping and preparative collection for protein sequencing. This system combined with a Frit-FAB mass spectrometer interface also provides the ability to obtain molecular ions for peptides of enzymatically digested proteins in the time it takes to obtain an HPLC chromatogram. The low flow rates permit introduction of the entire column effluent into the mass spectrometer. Detection limits of 0.5-5 pmol are routine. Proteolytic digests of recombinant human methionyl growth hormone and protein carboxyl methyltransferase have been used to demonstrate the HPLC and mass spectrometer performance.